Given the recently demonstrated ability of Adam8 to control neutrophil transmigration [64] and NLRP3 inflammasome activation [65], the processes tightly associated with colon inflammation [66,67], Adam8 can be considered as a novel promising master regulator of colitis and CAC; this requires further clarification. The gene discussed is NLRP3; the disease is colitis.